Skip to content

TMC114 appears to be strong PI option for salvage therapy

Myocardial infarction risk rises with each year of antiretroviral therapy, but remains low

Investigational NNRTI TMC278 swiftly cuts viral load in treatment-naive patients

Therapeutic vaccine plus interleukin-2 shows best viral control in treatment breaks

Pre-exposure prophylaxis may only offer limited benefit

Vanguard treatment programmes pave the way to scale up

Little difference in child transmission rates between formula feed and breast-plus-AZT

Two new drug classes given to people with HIV for the first time

Pregnant women with CD4 cell counts over 250 not at greater risk of nevirapine-related toxicity in Kenyan study